ES8505691A1 - Un procedimiento para preparar derivados de cefem - Google Patents

Un procedimiento para preparar derivados de cefem

Info

Publication number
ES8505691A1
ES8505691A1 ES534297A ES534297A ES8505691A1 ES 8505691 A1 ES8505691 A1 ES 8505691A1 ES 534297 A ES534297 A ES 534297A ES 534297 A ES534297 A ES 534297A ES 8505691 A1 ES8505691 A1 ES 8505691A1
Authority
ES
Spain
Prior art keywords
carboxymethoxyphenylacetamido
substituted
same
alkanoyloxy
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534297A
Other languages
English (en)
Other versions
ES534297A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21772682A external-priority patent/JPS59108791A/ja
Priority claimed from JP3601783A external-priority patent/JPS59161389A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES8505691A1 publication Critical patent/ES8505691A1/es
Publication of ES534297A0 publication Critical patent/ES534297A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DECEFEM.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) O UNA SAL DEL MISMO, CON UN COMPUESTO DE FORMULA (III) EN UN DISOLVENTE INERTE Y A UNA TEMPERATURA ENTRE C50JC Y B50JC, PARA OBTENER UN COMPUESTO DE FORMULA (I), Y SUS SALES FARMACEUTICAMENTE ACEPTABLES O SIENDO R1 HIDROXI, ALCANOILOXI DE (1 A 4), R2 -H O METOXI, R3 ALCANOILOXI DE (1 A 4), UN ANILLO HETEROCICLICO-TIO U OTROS, A UN GRUPO DE FORMULA (IV); Y R4 Y R5 H O UN GRUPO ALQUILO DE (1 A 4).SE UTILIZA COMO AGENTES ANTIBACTERIANAS CONTRA BACTERIAS GAMMA-(-).
ES534297A 1982-12-14 1984-07-13 Un procedimiento para preparar derivados de cefem Granted ES534297A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21772682A JPS59108791A (ja) 1982-12-14 1982-12-14 ７−カルボキシメトキシフエニルアセトアミド−３−セフエム誘導体、その製造方法およびそれからなる抗菌剤
JP3601783A JPS59161389A (ja) 1983-03-07 1983-03-07 ７−カルボキシメトキシフエニルアセトアミドセフエム誘導体，その製造法およびそれからなる抗菌剤

Publications (2)

Publication Number Publication Date
ES8505691A1 true ES8505691A1 (es) 1985-06-01
ES534297A0 ES534297A0 (es) 1985-06-01

Family

ID=26375029

Family Applications (2)

Application Number Title Priority Date Filing Date
ES528003A Expired ES8506025A1 (es) 1982-12-14 1983-12-13 Un procedimiento para preparar derivados de cefem
ES534297A Granted ES534297A0 (es) 1982-12-14 1984-07-13 Un procedimiento para preparar derivados de cefem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES528003A Expired ES8506025A1 (es) 1982-12-14 1983-12-13 Un procedimiento para preparar derivados de cefem

Country Status (16)

Country Link
US (1) US4546176A (es)
KR (1) KR840007012A (es)
AT (1) ATA435283A (es)
AU (1) AU2082783A (es)
BE (1) BE898442A (es)
CH (1) CH656131A5 (es)
DE (1) DE3345093A1 (es)
DK (1) DK572183A (es)
ES (2) ES8506025A1 (es)
FR (1) FR2569195B1 (es)
GB (1) GB2132613B (es)
IT (1) IT1169969B (es)
NL (1) NL8304272A (es)
PH (1) PH20168A (es)
SE (1) SE8306882L (es)
YU (1) YU237283A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
US5244892A (en) * 1990-10-16 1993-09-14 Kyorin Pharmaceutical Co., Ltd. Cephem compounds, and antibacterial agents
NZ290722A (en) * 1994-08-02 1999-03-29 Procter & Gamble A process for making derivatives of quinolonyl lactam (qla's); intermediates
JPH10504815A (ja) * 1994-08-02 1998-05-12 ザ、プロクター、エンド、ギャンブル、カンパニー 抗微生物化合物の製造方法
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
JP2006523229A (ja) * 2003-03-05 2006-10-12 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性複素環式化合物ならびにその製造および使用方法
US20070149463A1 (en) * 2003-10-30 2007-06-28 Oyelere Adegboyega K Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) * 2003-11-18 2007-05-17 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
CN102816194A (zh) * 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
SE8009049L (sv) * 1980-03-04 1981-09-05 Eisai Co Ltd 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar
US4468394A (en) * 1981-04-02 1984-08-28 Eisai Co., Ltd. Cephalosporin compounds

Also Published As

Publication number Publication date
YU237283A (en) 1986-04-30
IT1169969B (it) 1987-06-03
DE3345093A1 (de) 1984-06-14
IT8324122A0 (it) 1983-12-12
NL8304272A (nl) 1984-07-02
SE8306882L (sv) 1984-06-15
DK572183A (da) 1984-06-27
ES528003A0 (es) 1985-06-16
SE8306882D0 (sv) 1983-12-13
US4546176A (en) 1985-10-08
FR2569195A1 (fr) 1986-02-21
ES8506025A1 (es) 1985-06-16
PH20168A (en) 1986-10-09
GB2132613A (en) 1984-07-11
ATA435283A (de) 1986-12-15
GB2132613B (en) 1986-05-08
KR840007012A (ko) 1984-12-04
CH656131A5 (de) 1986-06-13
ES534297A0 (es) 1985-06-01
AU2082783A (en) 1984-06-21
GB8329554D0 (en) 1983-12-07
DK572183D0 (da) 1983-12-13
BE898442A (fr) 1984-06-13
FR2569195B1 (fr) 1987-01-09

Similar Documents

Publication Publication Date Title
ES8506025A1 (es) Un procedimiento para preparar derivados de cefem
CA2096969A1 (en) 6-0-methylerythromycin a derivatives
ES8306157A1 (es) Un procedimiento para la produccion de un acido 7-(amino sustituido o no sustituido)-3-metil sustituido-a3-cefem-4-carboxilico.
ES8704943A1 (es) Un procedimiento para la fabricacion de derivados de cefalosporina.
ES2001794A6 (es) Un procedimiento para la preparacion de derivados de quinolina
EP0612751A3 (en) Compounds for the preparation of cephem derivatives.
ES8606360A1 (es) Un derivado de cefalosporina.
ES8202021A1 (es) Un procedimiento para la preparacion de un compuesto de ce- falosporina
HUT73172A (en) 3`-aziridino-anthracycline derivatives, pharmaceutical compns. contg. the said compds, process to prepare them and their use
ES8302021A1 (es) Procedimiento para la preparacion de 3-0-desmenlistamicina b.
IE43346L (en) Cephalosporin derivatives.
ES8304973A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos.
EP0287116A3 (en) Thiadiazolylacetamide cephem derivatives
ES2014041A6 (es) Un procedimiento para preparar un derivado de amina.
ES8307819A1 (es) "un metodo de producir derivados de cefalosporina".
ES454469A1 (es) Un procedimiento de produccion de derivados de 7-(4-carboxi-butiramido)-7-metoxicefalosporina.
ES8201587A1 (es) Procedimiento de producir compuestos cefalosporinicos anti- microbianos
ES8200650A1 (es) Procedimiento para preparar derivados de 2,5-dialcohilfeni- lurea
JPS56123990A (en) 7- n-acylamino-alpha-arylacetamide -3- substituted or unsubstituted-1-pyridiniummethyl cephalosporins
AU2231897A (en) Tricyclic compounds, their production and use
ES8506313A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo(3.2.0)hepteno.